Leflunomide therapy for BK virus allograft nephropathy in pediatric and young adult kidney transplant recipients

Pediatric Transplantation

Volumn 14, Issue 1, 2010, Pages 145-150

  Araya, Carlos E ^a   Garin, Eduardo H ^a   Neiberger, Richard E ^a   Dharnidharka, Vikas R ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

BK virus; Kidney transplant; Leflunomide; Pediatrics

Indexed keywords

CIDOFOVIR; CREATININE; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; TERIFLUNOMIDE;

ABSENCE OF SIDE EFFECTS; ADULT; ANTIVIRAL ACTIVITY; ARTICLE; BK VIRUS; CASE REPORT; CHILD; CREATININE BLOOD LEVEL; DRUG DOSE ESCALATION; DRUG TOLERABILITY; DRUG WITHDRAWAL; GRAFT FAILURE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; PEDIATRIC SURGERY; TREATMENT DURATION; VIRUS INFECTION; VIRUS LOAD;

ANTIVIRAL AGENTS; BK VIRUS; CHILD; DNA, VIRAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FOLLOW-UP STUDIES; HUMANS; ISOXAZOLES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; POLYOMAVIRUS INFECTIONS; TRANSPLANTATION, HOMOLOGOUS; TUMOR VIRUS INFECTIONS; YOUNG ADULT;

EID: 74349124390     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2009.01183.x     Document Type: Article

References (30)

1. Gardner SD, Field AM, Coleman DV, Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971 : 1 : 1253 1257.
2. Purighalla R, Shapiro R, Mccauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995 : 26 : 671 673.
3. Dharnidharka VR, Cherikh WC, Abbott KC. An OPTN analysis of national registry data on treatment for BK virus (TBKV) allograft nephropathy in the United States. Transplantation (in press).
4. Smith JM, Dharnidharka VR, Talley L, Martz K, Mcdonald RA. BK virus nephropathy in pediatric renal transplant recipients: An analysis of the North American Pediatric Renal Trials and Collaborative Studies (NAPRTCS) registry. Clin J Am Soc Nephrol 2007 : 2 : 1037 1042.
5. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 2008 : 85 : 850 854.
6. Koch MJ, Bohl DL, Miller BW, Mwintshi K, Lambert M, Brennan DC. Long term (median 5 year) follow up of preemptive immunosuppression reduction for BK viremia. Am J Transplant 2007 : 7 (Suppl 2 151, Abstract.
7. Chong AS, Zeng H, Knight DA, et al. Concurrent antiviral and immunosuppressive activities of leflunomide in vivo. Am J Transplant 2006 : 6 : 69 75.
8. Farasati NA, Shapiro R, Vats A, Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005 : 79 : 116 117.
9. Duclos AJ, Krishnamurthi V, Lard M, et al. Prevalence and clinical course of BK virus nephropathy in pancreas after kidney transplant patients. Transplant Proc 2006 : 38 : 3666 3672.
10. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006 : 81 : 704 710.
11. Zavos G, Gazouli M, Psimenou E, et al. Polyomavirus BK infection in Greek renal transplant recipients. Transplant Proc 2004 : 36 : 1413 1414.
12. Crew RJ, Markowitz G, Radhakrishnan J. Therapeutic options in BK virus-associated interstitial nephritis. Kidney Int 2006 : 70 : 399 402.
13. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005 : 352 : 1157 1158.
14. Teschner S, Geyer M, Wilpert J, et al. Remission of polyomavirus-induced graft nephropathy treated with low-dose leflunomide. Nephrol Dial Transplant 2006 : 21 : 2039 2040.
15. Ott U, Steiner T, Busch M, Gerth J, Wolf G. A single-center experience with BK virus nephropathy. Clin Nephrol 2008 : 69 : 244 250.
16. Bansal S, Lucia MS, Wiseman A. A case of polyomavirus-associated nephropathy presenting late after transplantation. Nat Clin Pract Nephrol 2008 : 4 : 283 287.
17. Leca N, Muczynski KA, Jefferson JA, et al. Higher levels of leflunomide are associated with hemolysis and are not superior to lower levels for BK virus clearance in renal transplant patients. Clin J Am Soc Nephrol 2008 : 3 : 829 835.
18. Basse G, Mengelle C, Kamar N, et al. Prospective evaluation of BK virus DNAemia in renal transplant patients and their transplant outcome. Transplant Proc 2007 : 39 : 84 87.
19. Faguer S, Hirsch HH, Kamar N, et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 2007 : 20 : 962 969.
20. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 2008 : 12 : 790 795.
21. Reploeg MD, Storch GA, Clifford DB. Bk virus: A clinical review. Clin Infect Dis 2001 : 33 : 191 202.
22. Hirsch HH, Steiger J. Polyomavirus BK. Lancet Infect Dis 2003 : 3 : 611 623.
23. Dall A, Hariharan S. BK virus nephritis after renal transplantation. Clin J Am Soc Nephrol 2008 : 3 : S68 75.
24. Smith JM, Mcdonald RA, Finn LS, Healey PJ, Davis CL, Limaye AP. Polyomavirus nephropathy in pediatric kidney transplant recipients. Am J Transplant 2004 : 4 : 2109 2117.
25. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002 : 347 : 488 496.
26. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005 : 79 : 1277 1286.
27. Medipalli R, Vasudeev B, Zhu Y, et al. Improved outcomes of BKVN: Impact of BK virus surveillance protocol. Am J Transplant 2007 : 7 : 150. Abstract.
28. Bonvoisin C, Weekers L, Xhignesse P, Grosch S, Milicevic M, Krzesinski JM. Polyomavirus in renal transplantation: A hot problem. Transplantation 2008 : 85 : S42 48.
29. Acott PD, Hirsch HH. BK virus infection, replication, and diseases in pediatric kidney transplantation. Pediatr Nephrol 2007 : 22 : 1243 1250.
30. Shi J, Kovacs SJ, Wang Y, Ludden TM, Bhargava VO. Population pharmacokinetics of the active metabolite of leflunomide in pediatric subjects with polyarticular course juvenile rheumatoid arthritis. J Pharmacokinet Pharmacodyn 2005 : 32 : 419 439.